Journal article
Anti-epithelial-derived cytokines for severe asthma: Systematic review and meta-analysis
Abstract
BACKGROUND: Therapies directed against epithelial-derived cytokines, often referred to as alarmins, have been studied in large randomized trials, and reports suggest possible benefit for non-type 2 as well as type 2 severe asthma.
METHODS: We performed a systematic review of Medline, Embase, Cochrane Central Register of Controlled Trials, Medline In-Process, and Web of Science databases from inception to March 2022. We performed a …
Authors
Su J; Pitre T; Desai K; Mah J; Nair P; Ho T; Zeraatkar D
Journal
The Journal of Allergy and Clinical Immunology, Vol. 151, No. 6, pp. 1566–1576
Publisher
Elsevier
Publication Date
6 2023
DOI
10.1016/j.jaci.2023.02.021
ISSN
0091-6749